According to industry research conducted by Thermo Fisher Scientific's PPD clinical research division, almost two-thirds of drug developers are now embracing functional service provider (FSP) outsourcing for their clinical research initiatives. This surge in FSP outsourcing's popularity can be attributed to its effective response to four critical challenges within the industry:
- Addressing the growing number of vendors involved in the clinical research process.
- Meeting the ongoing imperative to streamline drug development timelines and expedite product launches.
- Coping with an unprecedented demand for qualified talent and a limited supply thereof.
- Ensuring strong relationships with top research sites to be recognized as the preferred sponsor.
Discover recent case studies where clients have leveraged PPD's clinical research services to surmount these challenges and accelerate their achievements through our functional service partnership model.